Search results

ANSTO's unique capabilities are being used to develop a quick analytical tool to determine the geographic origin of seafood and authenticates quality.

The physics and chemistry used at ANSTO is built upon, in significant part, by pioneering female scientists who were sidelined, expelled, or simply not credited appropriately for their achievements.

Research undertaken by Flinders University, the University of Cincinnati (US), Guangzhou University (China) and ANSTO has evaluated a new process to encapsulate fish oil in nanoparticles

Successful synthesis of nano-material that improves catalytic converter efficiency.

The cost of building radiation-hardness testing into the design and qualification of electronics is typically well under one per cent of a major project’s budget.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

Ultra-realistic simulations of a PET imaging system for next-generation radiotherapy: Collaboration giving back to the open source science community.

The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.

The Platypus instrument can be used to study all-manner of surface-science and interface problems, particularly related to magnetic recording materials and for polymer coatings, biosensors and artificial biological membranes.

Access to a ‘window into the cell’ with University of Wollongong cryogenic electron microscope at ANSTO.

Meeting of minds about potential next-generation cancer treatment for Australians

This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program